Records show Perdue stock trades not made by outside adviser: report

Reading now: 109
foxnews.com

A recent report on Republican Georgia Sen. David Perdue’s sale of more than $1 million worth of Cardlytics stock in March following an email from the banking company’s CEO contradicts a claim from his office that the transaction was not his decision.

Perdue sold off roughly 20% of his stake in Cardlytics, for which he once sat on the board, after CEO Scott Grimes emailed him in January referencing “upcoming changes,” and soon before the coronavirus pandemic prompted an economic shutdown.

Read more on foxnews.com
The website starsalert.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA